vs
Side-by-side financial comparison of Rumble Inc. (RUM) and ARS Pharmaceuticals, Inc. (SPRY). Click either name above to swap in a different company.
ARS Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($28.1M vs $27.1M, roughly 1.0× Rumble Inc.). Rumble Inc. runs the higher net margin — -120.8% vs -147.1%, a 26.3% gap on every dollar of revenue. On growth, Rumble Inc. posted the faster year-over-year revenue change (-10.5% vs -67.6%).
Rumble is a Canadian-American online video platform, web hosting, and cloud services business headquartered in Toronto, Canada, with its U.S. headquarters in Longboat Key, Florida. It was founded in 2013 by Chris Pavlovski, a Canadian technology entrepreneur. Rumble's cloud services business hosts Truth Social, and the video platform is popular among American conservative and far-right users. Rumble has been described as "alt-tech".
ARS Pharmaceuticals, Inc. is a late-stage biopharmaceutical firm specializing in the development and commercialization of novel therapies for severe allergic reactions, most notably needle-free epinephrine delivery solutions for anaphylaxis. It primarily operates in the North American market, catering to both pediatric and adult patient groups at risk of life-threatening allergic responses.
RUM vs SPRY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $27.1M | $28.1M |
| Net Profit | $-32.7M | $-41.3M |
| Gross Margin | 5.5% | — |
| Operating Margin | -131.1% | -147.6% |
| Net Margin | -120.8% | -147.1% |
| Revenue YoY | -10.5% | -67.6% |
| Net Profit YoY | 86.2% | -182.8% |
| EPS (diluted) | $-0.13 | $-0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $27.1M | $28.1M | ||
| Q3 25 | $24.8M | $32.5M | ||
| Q2 25 | — | $15.7M | ||
| Q1 25 | $23.7M | $8.0M | ||
| Q4 24 | $30.2M | $86.6M | ||
| Q3 24 | $25.1M | $2.1M | ||
| Q2 24 | $22.5M | $500.0K | ||
| Q1 24 | $17.7M | $0 |
| Q4 25 | $-32.7M | $-41.3M | ||
| Q3 25 | $-16.3M | $-51.2M | ||
| Q2 25 | — | $-44.9M | ||
| Q1 25 | $-2.7M | $-33.9M | ||
| Q4 24 | $-236.8M | $49.9M | ||
| Q3 24 | $-31.5M | $-19.1M | ||
| Q2 24 | $-26.8M | $-12.5M | ||
| Q1 24 | $-43.3M | $-10.3M |
| Q4 25 | 5.5% | — | ||
| Q3 25 | -1.8% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -26.7% | — | ||
| Q4 24 | -14.2% | — | ||
| Q3 24 | -45.4% | — | ||
| Q2 24 | -58.8% | — | ||
| Q1 24 | -79.5% | — |
| Q4 25 | -131.1% | -147.6% | ||
| Q3 25 | -113.6% | -163.7% | ||
| Q2 25 | — | -302.9% | ||
| Q1 25 | -153.5% | -466.3% | ||
| Q4 24 | -80.1% | 54.5% | ||
| Q3 24 | -131.0% | -1051.6% | ||
| Q2 24 | -172.7% | -3068.0% | ||
| Q1 24 | -197.4% | — |
| Q4 25 | -120.8% | -147.1% | ||
| Q3 25 | -65.7% | -157.4% | ||
| Q2 25 | — | -285.6% | ||
| Q1 25 | -11.2% | -425.7% | ||
| Q4 24 | -783.2% | 57.7% | ||
| Q3 24 | -125.9% | -925.0% | ||
| Q2 24 | -119.2% | -2503.2% | ||
| Q1 24 | -244.1% | — |
| Q4 25 | $-0.13 | $-0.41 | ||
| Q3 25 | $-0.06 | $-0.52 | ||
| Q2 25 | — | $-0.46 | ||
| Q1 25 | $-0.01 | $-0.35 | ||
| Q4 24 | $-1.17 | $0.52 | ||
| Q3 24 | $-0.15 | $-0.20 | ||
| Q2 24 | $-0.13 | $-0.13 | ||
| Q1 24 | $-0.21 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $237.9M | $245.0M |
| Total DebtLower is stronger | — | $96.4M |
| Stockholders' EquityBook value | $274.8M | $114.3M |
| Total Assets | $336.8M | $327.7M |
| Debt / EquityLower = less leverage | — | 0.84× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $237.9M | $245.0M | ||
| Q3 25 | $269.8M | $288.2M | ||
| Q2 25 | — | $240.1M | ||
| Q1 25 | $301.3M | $275.7M | ||
| Q4 24 | $114.0M | $314.0M | ||
| Q3 24 | $132.0M | $204.6M | ||
| Q2 24 | $154.2M | $218.7M | ||
| Q1 24 | $183.8M | $223.6M |
| Q4 25 | — | $96.4M | ||
| Q3 25 | — | $96.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $274.8M | $114.3M | ||
| Q3 25 | $302.2M | $147.7M | ||
| Q2 25 | — | $192.3M | ||
| Q1 25 | $339.6M | $229.0M | ||
| Q4 24 | $-63.1M | $256.8M | ||
| Q3 24 | $166.1M | $201.0M | ||
| Q2 24 | $192.7M | $215.2M | ||
| Q1 24 | $210.7M | $223.9M |
| Q4 25 | $336.8M | $327.7M | ||
| Q3 25 | $367.2M | $372.8M | ||
| Q2 25 | — | $313.5M | ||
| Q1 25 | $391.1M | $327.3M | ||
| Q4 24 | $195.3M | $351.2M | ||
| Q3 24 | $217.2M | $217.6M | ||
| Q2 24 | $243.2M | $222.0M | ||
| Q1 24 | $263.0M | $227.6M |
| Q4 25 | — | 0.84× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-29.4M | $-43.5M |
| Free Cash FlowOCF − Capex | $-31.7M | — |
| FCF MarginFCF / Revenue | -117.2% | — |
| Capex IntensityCapex / Revenue | 8.5% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-70.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-29.4M | $-43.5M | ||
| Q3 25 | $-10.6M | $-47.0M | ||
| Q2 25 | — | $-39.6M | ||
| Q1 25 | $-14.5M | $-40.7M | ||
| Q4 24 | $-12.4M | $42.0M | ||
| Q3 24 | $-19.1M | $-14.5M | ||
| Q2 24 | $-21.7M | $-7.3M | ||
| Q1 24 | $-33.9M | $-6.7M |
| Q4 25 | $-31.7M | — | ||
| Q3 25 | $-12.0M | $-47.2M | ||
| Q2 25 | — | $-39.6M | ||
| Q1 25 | $-14.6M | $-40.8M | ||
| Q4 24 | $-12.4M | $41.7M | ||
| Q3 24 | $-19.9M | $-14.6M | ||
| Q2 24 | $-23.1M | $-7.3M | ||
| Q1 24 | $-34.3M | $-6.8M |
| Q4 25 | -117.2% | — | ||
| Q3 25 | -48.6% | -145.4% | ||
| Q2 25 | — | -252.2% | ||
| Q1 25 | -61.7% | -512.1% | ||
| Q4 24 | -40.9% | 48.2% | ||
| Q3 24 | -79.5% | -706.3% | ||
| Q2 24 | -102.8% | -1463.4% | ||
| Q1 24 | -193.3% | — |
| Q4 25 | 8.5% | 0.0% | ||
| Q3 25 | 5.7% | 0.6% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | 0.6% | 1.1% | ||
| Q4 24 | 0.1% | 0.3% | ||
| Q3 24 | 3.4% | 6.8% | ||
| Q2 24 | 6.1% | 7.6% | ||
| Q1 24 | 2.4% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.84× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RUM
| Audience Monetization | $23.8M | 88% |
| Other Initiatives | $3.3M | 12% |
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
